Detailansicht

Wissensnetz

Person

Thomas Zeller (1960-)

Arzt

Name	Thomas Zeller
Zeit	1960- (Lebensdaten)
Ort	Erlangen (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Arzt (charakteristischer Beruf)
Beziehung	Klinik für Kardiologie und Angiologie II
Weitere Angaben	Diss. Med. Fak. der Univ. Freiburg (Breisgau) und Habil. Fach Innere Medizin der Univ. Freiburg (Breisgau)
Datensatztyp	Person
GND-Nummer	133031969
Datensatz-ID	133031969
Beteiligt an alle anzeigen Antimicrobial resistance is not increasing in subsequent cases of ischaemic foot infections, a single‐centre cohort from 2012 to 2021 Catheter-directed thrombolysis in the management of thrombotic peripheral artery occlusions—acute and mid-term clinical outcomes Evaluation der Mortalität dialysepflichtiger Patientinnen und Patienten nach endovaskulären Interventionen mit und ohne Paclitaxel-beschichteten Devices Evaluation morphologischer Unterschiede von In-Stent Restenosierungen nach Stentangioplastie mit unterschiedlichen Stentdesigns femoropopliteal Evaluation of acute and midterm outcomes after complex combined antegrade/retrograde recanalization for occlusions of the femoropopliteal and infrapopliteal arteries Five-year safety and effectiveness of paclitaxel drug-coated balloons alone or with provisional bare metal stenting for real-world femoropopliteal lesions: in.pact global study subgroup analysis Multimodale Bildgebung zur Diagnostik der vulnerablen Plaque von Arteria carotis Stenosen mit histopathologischer Referenz: klinische Relevanz diagnostischer Parameter über den Stenosegrad hinaus Percutaneous intervention versus surgery in the treatment of common femoral artery lesions: study protocol for the prospective, multi-center, randomized PESTO-CFA trial Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value The BioMimics 3D helical centreline nitinol stent in chronic limb threatening ischaemia and complex lesions: three year outcomes of the MIMICS-3D registry Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to support empirical antibiotic therapy decisions in infected ischemic leg ulcers - a feasibility study Treatment of Complex Femoro-popliteal Lesions: Time to Revise the Guidelines According to Clinical Reality Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis 5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE Arterial leg ulcers—Bacterial patterns, antimicrobial resistance and clinical characteristics, a retrospective single-centre cohort, 2012–2021 BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design Evaluation of the MYNX CONTROL™ arterial closure system for achieving primary hemostasis after arterial femoral access following peripheral arterial interventions, compared to the FemoSealTM closure system Five-year outcomes after paclitaxel drug-coated balloon treatment of femoropopliteal lesions in diabetic and chronic limb-threatening ischemia cohorts: IN.PACT Global study post hoc analysis Impact of COVID-19 Pandemic on Clinical Care of Peripheral Arterial Disease Patients: A Single-Center Experience Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry Optimized drug‐coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24‐month results in standard and long lesions Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial Sirolimus-Coated Balloon Angioplasty of Infra-popliteal Lesions for the Treatment of Chronic Limb-Threatening Ischemia: Study Protocol for the Randomized Controlled LIMES Study Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis BioMimics 3D vascular stent system for femoropopliteal interventions : : two-year results from the real-world multicenter MIMICS-3D registry Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: Primary results of the EMINENT randomized trial Evaluation der Akut- und Langzeitergebnisse nach endoprothetischer Ausschaltung von Poplitealaneurysmen mittels Viabahn® Retrospektive, monozentrische Datenanalyse = Evaluation der Akut- und Langzeitergebnisse nach endoprothetischer Ausschaltung von Poplitealaneurysmen mittels Viabahn[R] Retrospektive, monozentrische Datenanalyse Evaluation of stent angioplasty in the treatment of arteriosclerotic lesions of the common femoral artery First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized disrupt PAD III Trial Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial Long-term outcomes of the 150 mm drug-coated balloon cohort from the IN.PACT global study Massive cardiopulmonary cement embolism with cardiac perforation after vertebroplasty: a case series Sex-related outcomes following drug balloon angioplasty in patients from the BIOLUX P-III registry: A subgroup analysis Sirolimus-coated balloon angioplasty of infra-popliteal lesions for the treatment of chronic limb-threatening ischemia: study protocol for the randomized controlled LIMES study The impact of chronic kidney disease on mid-term outcomes after revascularisation of peripheral arterial occlusive disease: results from a prospective cohort study Time for a standardized common femoral artery classification system Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry 1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon Correction to: Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-Month outcomes in the full cohort of BIOLUX P-III global registry Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial Intravascular lithotripsy for peripheral artery calcification Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-month outcomes in the full cohort of BIOLUX P-III Global Registry Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX drug-eluting peripheral stent Provisional focal stenting of complex femoropopliteal lesions using the Multi-LOC multiple stent delivery system – 12-month results from the LOCOMOTIVE EXTENDED study The prospective GermanVasc cohort study : : endovascular and open-surgical treatment of symptomatic peripheral artery disease The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent Accuracy of carotid artery stenosis quantification with 4-D-supported 3-D power-doppler versus color-doppler and 2-D blood velocity-based duplex ultrasonography Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: one-year interim results of SPACE-2 COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials Paclitaxel-coated balloon for the treatment of infrainguinal disease: 12-month outcomes in the all-comers cohort of BIOLUX p-III global registry

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Thomas Zeller (1960-)

Antimicrobial resistance is not increasing in subsequent cases of ischaemic foot infections, a single‐centre cohort from 2012 to 2021

Catheter-directed thrombolysis in the management of thrombotic peripheral artery occlusions—acute and mid-term clinical outcomes

Evaluation der Mortalität dialysepflichtiger Patientinnen und Patienten nach endovaskulären Interventionen mit und ohne Paclitaxel-beschichteten Devices

Evaluation morphologischer Unterschiede von In-Stent Restenosierungen nach Stentangioplastie mit unterschiedlichen Stentdesigns femoropopliteal

Evaluation of acute and midterm outcomes after complex combined antegrade/retrograde recanalization for occlusions of the femoropopliteal and infrapopliteal arteries

Five-year safety and effectiveness of paclitaxel drug-coated balloons alone or with provisional bare metal stenting for real-world femoropopliteal lesions: in.pact global study subgroup analysis

Multimodale Bildgebung zur Diagnostik der vulnerablen Plaque von Arteria carotis Stenosen mit histopathologischer Referenz: klinische Relevanz diagnostischer Parameter über den Stenosegrad hinaus

Percutaneous intervention versus surgery in the treatment of common femoral artery lesions: study protocol for the prospective, multi-center, randomized PESTO-CFA trial

Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value

The BioMimics 3D helical centreline nitinol stent in chronic limb threatening ischaemia and complex lesions: three year outcomes of the MIMICS-3D registry

Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to support empirical antibiotic therapy decisions in infected ischemic leg ulcers - a feasibility study

Treatment of Complex Femoro-popliteal Lesions: Time to Revise the Guidelines According to Clinical Reality

Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Arterial leg ulcers—Bacterial patterns, antimicrobial resistance and clinical characteristics, a retrospective single-centre cohort, 2012–2021

BioMimics 3D stent in femoropopliteal lesions: 3-year outcomes with propensity matching for drug-coated balloons

Evaluation of femoropopliteal in-stent restenosis characteristics stratified by stent design

Evaluation of the MYNX CONTROL™ arterial closure system for achieving primary hemostasis after arterial femoral access following peripheral arterial interventions, compared to the FemoSealTM closure system

Five-year outcomes after paclitaxel drug-coated balloon treatment of femoropopliteal lesions in diabetic and chronic limb-threatening ischemia cohorts: IN.PACT Global study post hoc analysis

Impact of COVID-19 Pandemic on Clinical Care of Peripheral Arterial Disease Patients: A Single-Center Experience

Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry

Optimized drug‐coated balloon angioplasty of the superficial femoral and proximal popliteal arteries using the Tack Endovascular System: Tack Optimized Balloon Angioplasty (TOBA) III 24‐month results in standard and long lesions

Long-Term Effectiveness and Safety of Femoropopliteal Drug-Coated Balloon Angioplasty : 5-Year Results of the Randomized Controlled EffPac Trial

Sirolimus-Coated Balloon Angioplasty of Infra-popliteal Lesions for the Treatment of Chronic Limb-Threatening Ischemia: Study Protocol for the Randomized Controlled LIMES Study

Long-Term Outcomes of the 150 mm Drug-Coated Balloon Cohort from the IN.PACT Global Study

Sex-Related Outcomes Following Drug Balloon Angioplasty in Patients from the BIOLUX P-III Registry: A Subgroup Analysis

BioMimics 3D vascular stent system for femoropopliteal interventions : : two-year results from the real-world multicenter MIMICS-3D registry

Determinants of drug-coated balloon failure in patients undergoing femoropopliteal arterial intervention

Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: Primary results of the EMINENT randomized trial

Evaluation of stent angioplasty in the treatment of arteriosclerotic lesions of the common femoral artery

First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

Individual patient data meta‐analysis of patients treated with a heparin‐bonded Viabahn in the femoropopliteal artery for chronic limb‐threatening ischemia

Intravascular lithotripsy for peripheral artery calcification: mid-term outcomes from the randomized disrupt PAD III Trial

Long-term effectiveness and safety of femoropopliteal drug-coated balloon angioplasty : : 5-year results of the randomized controlled EffPac trial

Long-term outcomes of the 150 mm drug-coated balloon cohort from the IN.PACT global study

Massive cardiopulmonary cement embolism with cardiac perforation after vertebroplasty: a case series

Sex-related outcomes following drug balloon angioplasty in patients from the BIOLUX P-III registry: A subgroup analysis

Sirolimus-coated balloon angioplasty of infra-popliteal lesions for the treatment of chronic limb-threatening ischemia: study protocol for the randomized controlled LIMES study

The impact of chronic kidney disease on mid-term outcomes after revascularisation of peripheral arterial occlusive disease: results from a prospective cohort study

Time for a standardized common femoral artery classification system

Correction to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry

1-year results from the RANGER II SFA randomized trial of the ranger drug-coated balloon

Correction to: Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-Month outcomes in the full cohort of BIOLUX P-III global registry

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial

Intravascular lithotripsy for peripheral artery calcification

Paclitaxel-coated balloon angioplasty for the treatment of infrainguinal arteries: 24-month outcomes in the full cohort of BIOLUX P-III Global Registry

Prediction model for freedom from TLR from a multi-study analysis of long-term results with the Zilver PTX drug-eluting peripheral stent

Provisional focal stenting of complex femoropopliteal lesions using the Multi-LOC multiple stent delivery system – 12-month results from the LOCOMOTIVE EXTENDED study

The prospective GermanVasc cohort study : : endovascular and open-surgical treatment of symptomatic peripheral artery disease

The SELUTION SLR™ drug-eluting balloon system for the treatment of symptomatic femoropopliteal lesions

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent

Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry

Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent

Accuracy of carotid artery stenosis quantification with 4-D-supported 3-D power-doppler versus color-doppler and 2-D blood velocity-based duplex ultrasonography

Angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy compared to best medical treatment: one-year interim results of SPACE-2

COMPARE: prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions

Paclitaxel exposure: Long‐term safety and effectiveness of a drug‐coated balloon for claudication in pooled randomized trials

Paclitaxel-coated balloon for the treatment of infrainguinal disease: 12-month outcomes in the all-comers cohort of BIOLUX p-III global registry